Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer
Teresa Cabezón, Irina Gromova, Pavel Gromov, Reza Rafiolsadat Serizawa, Vera Timmermans Wielenga, Niels Thorndahl Kroman, Julio E. Celis, José Moreira
Dive into the research topics of 'Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer'. Together they form a unique fingerprint.